Antineoplastic chemotherapy in Jehovah's Witness patients with acute myelogenous leukemia refusing blood products - a matched pair analysis.

Wilop, Stefan; Osieka, Rainhardt

Wilop, Stefan; Osieka, Rainhardt.

Affiliation

Wilop S; a Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Medical Faculty , RWTH Aachen University , Aachen , Germany.
Osieka R; a Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Medical Faculty , RWTH Aachen University , Aachen , Germany.

Hematology ; 23(6): 324-329, 2018 Jul.

Article in En | MEDLINE | ID: mdl-29212421

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Jehovah's Witnesses; Leukemia, Myeloid, Acute/drug therapy; Adult; Antineoplastic Combined Chemotherapy Protocols/adverse effects; Blood Transfusion; Cause of Death; Female; Humans; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute/mortality; Leukemia, Myeloid, Acute/therapy; Male; Matched-Pair Analysis; Middle Aged; Proportional Hazards Models; Retrospective Studies; Treatment Outcome; Treatment Refusal; Young Adult

Key words

Acute myelogenous leukemia; Jehovah's Wittness; blood product support; blood transfusions

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Antineoplastic Combined Chemotherapy Protocols / Jehovah's Witnesses Type of study: Observational_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Hematology Journal subject: HEMATOLOGIA Year: 2018 Document type: Article Affiliation country: Germany Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google